Shulan Guo
Overview
Explore the profile of Shulan Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ji J, Lu M, Guo S, Xiang B, Wu W, Li Y, et al.
Am J Nephrol
. 2025 Feb;
:1-17.
PMID: 39999819
Introduction: Different uremic solutes have varying degrees of clearances owing to different chemical properties and the pathological and physiological changes in the kidneys and peritoneum. Methods: The 5-year time profiles...
2.
Sun Z, Ning Y, Wu H, Guo S, Jiao X, Ji J, et al.
Cell Signal
. 2023 Sep;
111:110878.
PMID: 37657586
Cisplatin is a chemotherapeutic agent that is used extensively to treat solid tumors; however, its clinical application is limited by side effects, especially nephrotoxicity. Cisplatin-induced acute kidney injury (AKI) is...
3.
Guo S, Wu H, Ji J, Sun Z, Xiang B, Wu W, et al.
Ren Fail
. 2023 Apr;
45(1):2195014.
PMID: 37009921
Background: Gut dysbiosis in peritoneal dialysis (PD) patients causes chronic inflammation and metabolic disorders which result in a series of complications, probably playing an important role in PD technique failure....
4.
Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients
Bao M, Zhang P, Guo S, Zou J, Ji J, Ding X, et al.
Front Cell Infect Microbiol
. 2022 Oct;
12:639624.
PMID: 36237423
Peritoneal dialysis (PD) is a renal replacement therapy for end-stage renal disease. Gut microbiota-derived uremic solutes, indoxyl sulfate (IS), p-cresyl sulfate (PCS), and trimethylamine-N-oxide (TMAO) accumulate in PD patients. The...
5.
Cai Q, Sun Z, Xu S, Jiao X, Guo S, Li Y, et al.
Ren Fail
. 2022 Jul;
44(1):1169-1181.
PMID: 35837696
Acute kidney injury (AKI) is a serious condition with high mortality. The most common cause is kidney ischemia/reperfusion (IR) injury, which is thought to be closely related to pyroptosis. Disulfiram...